Back to Report Store Home

Opioids Market Overview – Increasing Concentration of Abuse-Resistant Branded Generics Alter Competitive Dynamics in this Flat Market

  • Published: Jan-2013
  • Report Code: GBIHC252MR
  • Report Format: pdf

Description

List of Figures

Figure 1: Opioids Market, Drivers and Barriers, 2012

Figure 2: Opioids Market, Global, R&D Pipeline by Phase (%), 2012

Figure 3: Opioids Market, Pipeline Analysis,,Opioid Compounds in Phase III

Figure 4: Opioids Market, Pipeline Analysis,,Opioid Compounds in Phase II

Figure 5: Opioids Market, Pipeline Analysis,,Opioid Compounds in Phase I

Figure 6: Opioids Market, Pipeline Analysis, Route of Administration for Pipeline Molecules Currently in Phase III

Figure 7: Opioids Market, Pipeline Analysis, Route of Administration for Pipeline Molecules Currently in Phase II

Figure 8: Opioids Market, Pipeline Analysis, Route of Administration for Pipeline Molecules Currently in Phase I

Figure 9: Opioids Market, M&As by Year, 2005–2012

Figure 10: Opioids Market, M&As by Value ($m), 2005–2012

Figure 11: Opioids Market, Licensing Agreements by Year, 2005–2012

Figure 12: Opioids Market, Licensing Agreements by Value ($m), 2005–2012

Figure 13: Opioids Market, Co-Development Agreements by Year, 2005–2012

License Details
Electronic PDF copy delivered via email. Report can be used by individual purchaser only.
Single User Licence
$3500
Electronic PDF copy delivered via email. Report can be shared by unlimited users within one corporate location, e.g. a regional office.
Site Licence
$7000
Electronic PDF copy delivered via email. Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company.
Global Licence
$10500
Email to a colleague Enquire Before Buying
Prefer to speak to a team member? Call us on:
+44 161 359 5414
Or click here to contact us
Secure Payments
Cards